L&C BIO Co.,LTD (KOSDAQ:290650)
South Korea flag South Korea · Delayed Price · Currency is KRW
85,300
-3,800 (-4.26%)
At close: Feb 6, 2026

L&C BIO Co.,LTD Revenue

L&C BIO Co.,LTD had revenue of 22.56B KRW in the quarter ending September 30, 2025, with 21.66% growth. This brings the company's revenue in the last twelve months to 79.99B, up 19.41% year-over-year. In the year 2024, L&C BIO Co.,LTD had annual revenue of 72.09B with 9.35% growth.

Revenue (ttm)
79.99B
Revenue Growth
+19.41%
P/S Ratio
26.49
Revenue / Employee
567.32M
Employees
141
Market Cap
2.12T

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202472.09B6.17B9.35%
Dec 31, 202365.93B13.35B25.40%
Dec 31, 202252.57B6.90B15.10%
Dec 31, 202145.68B12.70B38.53%
Dec 31, 202032.97B3.82B13.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Seegene458.94B
i-SENS313.10B
InBody Co.,Ltd226.62B
Osang Healthcare Co.,Ltd119.03B
Ray Co., Ltd.97.57B
Curexo27.85B
HASS Corp.17.18B
Seers Technology Co., LTD.11.42B
Revenue Rankings